Improving curcumin bactericidal potential against multi-drug resistant bacteria via its loading in polydopamine coated zinc-based metal-organic frameworks
Multi-drug resistant (MDR) bactearial strains have posed serious health issues, thus leading to a significant increase in mortality, morbidity, and the expensive treatment of infections. Metal-organic frameworks (MOFs), comprising metal ions and a variety of organic ligands, have been employed as an effective drug deliveryy vehicle due to their low toxicity, biodegradability, higher structural integrity and diverse surface functionalities. Polydopamine (PDA) is a versatile biocompatible polymer with several interesting properties, including the ability to adhere to biological surfaces. As a result, modifying drug delivery vehicles with PDA has the potential to improve their antimicrobial properties. This work describes the preparation of PDA-coated Zn-MOFs for improving curcumin's antibacterial properties against S. aureus and E. coli. Powder X-ray diffraction (P-XRD), FT-IR, scanning electron microscopy (SEM), and DLS were utilized to characterize PDA-coated Zn-MOFs. The curcumin loading and in vitro release of the prepared MOFs were also examined. Finally, the MOFs were tested for bactericidal ability against E. coli and S. aureus using an anti-bacterial assay and surface morphological analysis. Smaller size MOFs were capable of loading and releasing curcumin. The findings showed that as curcumin was encapsulated into PDA-coated MOFs, its bactericidal potential was significantly enhanced, and the findings were further supported by SEM which indicated the complete morphological distortion of the bacteria after treatment with PDA-Cur-Zn-MOFs. These studies clearly indicate that the PDA-Cur-Zn-MOFs developed in this study are extremely promising for long-term release of drugs to treat a wide range of microbial infections.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:30 |
---|---|
Enthalten in: |
Drug delivery - 30(2023), 1 vom: 04. Dez., Seite 2159587 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Jabbar, Abdul [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 01.02.2023 Date Revised 03.02.2023 published: Print Citation Status MEDLINE |
---|
doi: |
10.1080/10717544.2022.2159587 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM352291885 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM352291885 | ||
003 | DE-627 | ||
005 | 20231226053359.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/10717544.2022.2159587 |2 doi | |
028 | 5 | 2 | |a pubmed24n1174.xml |
035 | |a (DE-627)NLM352291885 | ||
035 | |a (NLM)36718806 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Jabbar, Abdul |e verfasserin |4 aut | |
245 | 1 | 0 | |a Improving curcumin bactericidal potential against multi-drug resistant bacteria via its loading in polydopamine coated zinc-based metal-organic frameworks |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.02.2023 | ||
500 | |a Date Revised 03.02.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Multi-drug resistant (MDR) bactearial strains have posed serious health issues, thus leading to a significant increase in mortality, morbidity, and the expensive treatment of infections. Metal-organic frameworks (MOFs), comprising metal ions and a variety of organic ligands, have been employed as an effective drug deliveryy vehicle due to their low toxicity, biodegradability, higher structural integrity and diverse surface functionalities. Polydopamine (PDA) is a versatile biocompatible polymer with several interesting properties, including the ability to adhere to biological surfaces. As a result, modifying drug delivery vehicles with PDA has the potential to improve their antimicrobial properties. This work describes the preparation of PDA-coated Zn-MOFs for improving curcumin's antibacterial properties against S. aureus and E. coli. Powder X-ray diffraction (P-XRD), FT-IR, scanning electron microscopy (SEM), and DLS were utilized to characterize PDA-coated Zn-MOFs. The curcumin loading and in vitro release of the prepared MOFs were also examined. Finally, the MOFs were tested for bactericidal ability against E. coli and S. aureus using an anti-bacterial assay and surface morphological analysis. Smaller size MOFs were capable of loading and releasing curcumin. The findings showed that as curcumin was encapsulated into PDA-coated MOFs, its bactericidal potential was significantly enhanced, and the findings were further supported by SEM which indicated the complete morphological distortion of the bacteria after treatment with PDA-Cur-Zn-MOFs. These studies clearly indicate that the PDA-Cur-Zn-MOFs developed in this study are extremely promising for long-term release of drugs to treat a wide range of microbial infections | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Polydopamine coating | |
650 | 4 | |a bactericidal potential | |
650 | 4 | |a characterization | |
650 | 4 | |a curcumin loading | |
650 | 4 | |a metal-organic frameworks | |
650 | 7 | |a polydopamine |2 NLM | |
650 | 7 | |a Metal-Organic Frameworks |2 NLM | |
650 | 7 | |a Curcumin |2 NLM | |
650 | 7 | |a IT942ZTH98 |2 NLM | |
650 | 7 | |a Zinc |2 NLM | |
650 | 7 | |a J41CSQ7QDS |2 NLM | |
650 | 7 | |a Polymers |2 NLM | |
650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
700 | 1 | |a Rehman, Khadija |e verfasserin |4 aut | |
700 | 1 | |a Jabri, Tooba |e verfasserin |4 aut | |
700 | 1 | |a Kanwal, Tasmina |e verfasserin |4 aut | |
700 | 1 | |a Perveen, Samina |e verfasserin |4 aut | |
700 | 1 | |a Rashid, Md Abdur |e verfasserin |4 aut | |
700 | 1 | |a Kazi, Mohsin |e verfasserin |4 aut | |
700 | 1 | |a Ahmad Khan, Saeed |e verfasserin |4 aut | |
700 | 1 | |a Saifullah, Salim |e verfasserin |4 aut | |
700 | 1 | |a Shah, Muhammad Raza |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Drug delivery |d 1996 |g 30(2023), 1 vom: 04. Dez., Seite 2159587 |w (DE-627)NLM09361134X |x 1521-0464 |7 nnns |
773 | 1 | 8 | |g volume:30 |g year:2023 |g number:1 |g day:04 |g month:12 |g pages:2159587 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/10717544.2022.2159587 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 30 |j 2023 |e 1 |b 04 |c 12 |h 2159587 |